Relationship between plasma concentrations and pharmacological effects of labetalol
- PMID: 14010
- DOI: 10.1007/BF00562897
Relationship between plasma concentrations and pharmacological effects of labetalol
Abstract
In healthy normal subjects following the administration of labetalol the pharmacological effects were measured and compared with the plasma concentrations achieved. The inhibition of exercise induced tachycardia and inhibition of exercise induced increases in systolic pressure were significantly related to the administered dose of labetalol. Labetalol was rapidly absorbed from the gastrointestinal tract and peak plasma concentrations occurred two hours after oral administration. There was a linear correlation (r = 0.84) between the logarithm of the plasma concentration and the maximum inhibition of exercise tachycardia at two hours. After intravenous administration there was an immediate reduction in systolic and diastolic blood pressure with a concomitant small increase in heart rate. There was a rapid decline in the associated plasma concentration but the pharmacological effects were maintained in excess of two hours. Our findings are consistent with those of others who have studied the relationship between pharmacological events and plasma concentrations after single doses of other adrenoceptor blocking drugs.
Similar articles
-
Pharmacology of combined alpha-beta-blockade. I.Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003. Drugs. 1984. PMID: 6151889 Review.
-
Pharmacological effects of labetalol in man.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3. Br J Clin Pharmacol. 1976. PMID: 10949 Review.
-
Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):240-43. Int J Clin Pharmacol Biopharm. 1979. PMID: 38214 Clinical Trial.
-
alpha- and beta-blockade with labetalol in acute myocardial infarction.J Cardiovasc Pharmacol. 1982 Nov-Dec;4(6):921-4. doi: 10.1097/00005344-198211000-00007. J Cardiovasc Pharmacol. 1982. PMID: 6185783
-
Pharmacological basis for antihypertensive effects of intravenous labetalol.Br Heart J. 1977 Jan;39(1):99-106. doi: 10.1136/hrt.39.1.99. Br Heart J. 1977. PMID: 12778 Free PMC article.
Cited by
-
Pharmacology of combined alpha-beta-blockade. I.Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003. Drugs. 1984. PMID: 6151889 Review.
-
The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.Br J Clin Pharmacol. 1982 Jul;14(1):73-8. doi: 10.1111/j.1365-2125.1982.tb04936.x. Br J Clin Pharmacol. 1982. PMID: 7104169 Free PMC article. Clinical Trial.
-
Clinical pharmacology of labetalol.Br J Clin Pharmacol. 1979;8(Suppl 2):89S-93S. Br J Clin Pharmacol. 1979. PMID: 43165 Free PMC article. Review.
-
Elimination kinetics of labetalol in severe renal failure.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):81S-86S. doi: 10.1111/j.1365-2125.1982.tb01893.x. Br J Clin Pharmacol. 1982. PMID: 7093103 Free PMC article.
-
Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.Br Heart J. 1982 Oct;48(4):364-71. doi: 10.1136/hrt.48.4.364. Br Heart J. 1982. PMID: 7126388 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources